We are live on ! Find out more
SCM

Salem Capital Management Portfolio holdings

AUM $126M
1-Year Est. Return 8.82%
This Fund
S&P 500
This Quarter Est. Return
+10.17%
1 Year Est. Return
-8.82%
3 Year Est. Return
+32.26%
5 Year Est. Return
+45.09%
10 Year Est. Return
AUM
$168M
AUM Growth
+$10.5M
Cap. Flow
-$3.6M
Cap. Flow %
-2.14%
Top 10 Hldgs %
45%
Holding
76
New
9
Increased
15
Reduced
17
Closed
2

Top Buys

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$3.47M
2
ERIC icon
Ericsson
ERIC
+$1.52M
3
NOK icon
Nokia
NOK
+$1.5M
4
MRK icon
Merck
MRK
+$531K
5
GPN icon
Global Payments
GPN
+$390K

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$5.67M
2
DD icon
DuPont de Nemours
DD
+$4.08M
3
HAL icon
Halliburton
HAL
+$1.69M
4
MSFT icon
Microsoft
MSFT
+$495K
5
SYK icon
Stryker
SYK
+$312K

Sector Composition

Rank Sector Weight
1 Technology 21.2%
2 Consumer Discretionary 16.65%
3 Healthcare 15.39%
4 Financials 12.35%
5 Industrials 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTWO icon
51
Vanguard Russell 2000 ETF
VTWO
$17.9B
$467K 0.28%
5,236
+800
+18% +$70.5K
NFG icon
52
National Fuel Gas
NFG
$7.65B
$452K 0.27%
9,040
AVB icon
53
AvalonBay Communities
AVB
$26.8B
$436K 0.26%
2,364
GPN icon
54
Global Payments
GPN
$22.8B
$395K 0.24%
+1,960
New +$390K
CVS icon
55
CVS Health
CVS
$122B
$384K 0.23%
5,105
NEE icon
56
NextEra Energy
NEE
$177B
$377K 0.22%
4,989
SYK icon
57
Stryker
SYK
$130B
$353K 0.21%
1,450
-1,300
-47% -$312K
UL icon
58
Unilever
UL
$136B
$281K 0.17%
4,477
AMGN icon
59
Amgen
AMGN
$222B
$274K 0.16%
1,100
SLB icon
60
SLB Ltd
SLB
$75B
$272K 0.16%
10,000
CAT icon
61
Caterpillar
CAT
$387B
$247K 0.15%
+1,066
New +$221K
GIS icon
62
General Mills
GIS
$19.7B
$243K 0.14%
3,970
IBM icon
63
IBM
IBM
$224B
$227K 0.14%
1,778
+104
+6% +$12.4K
CSX icon
64
CSX Corp
CSX
$93.1B
$224K 0.13%
6,957
CTAS icon
65
Cintas
CTAS
$81.3B
$222K 0.13%
2,600
KO icon
66
Coca-Cola
KO
$375B
$221K 0.13%
4,200
SO icon
67
Southern Company
SO
$107B
$221K 0.13%
3,550
COP icon
68
ConocoPhillips
COP
$141B
$212K 0.13%
+4,000
New +$197K
XOM icon
69
ExxonMobil
XOM
$634B
$209K 0.12%
+3,752
New +$197K
ABBV icon
70
AbbVie
ABBV
$435B
$206K 0.12%
1,900
-1,600
-46% -$171K
DOV icon
71
Dover
DOV
$28.4B
$206K 0.12%
+1,500
New +$191K
PH icon
72
Parker-Hannifin
PH
$135B
$205K 0.12%
+650
New +$188K
DD icon
73
DuPont de Nemours
DD
$19.2B
-45,737
Closed -$4.08M
HAL icon
74
Halliburton
HAL
$26.6B
-89,350
Closed -$1.69M

Similar funds

Salem Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Salem Capital Management held 76 positions worth $168M, up 6.7% from $157M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Salem Capital Management's Q1 2021 filing shows 9 new, 15 increased, 17 reduced and 2 closed positions. Its largest new stake was Freeport-McMoran: 107,150 shares worth $3.53M. The largest sale was Intel, an estimated $5.67M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Salem Capital Management's largest Q1 2021 buy was Freeport-McMoran: 107,150 shares worth $3.53M.
  • Salem Capital Management added most to Merck in Q1 2021, an estimated $531K increase.
  • Salem Capital Management's biggest Q1 2021 reduction was Intel, cutting an estimated $5.67M.
  • Salem Capital Management fully exited DuPont de Nemours in Q1 2021, selling an estimated $4.08M.
  • Salem Capital Management's ten largest holdings make up 45% of its $168M portfolio in Q1 2021.
  • Salem Capital Management opened 9 new positions and closed 2 in Q1 2021.
  • Salem Capital Management's portfolio value rose 6.7% quarter-over-quarter to $168M.

Based on Salem Capital Management's 13F filing for Q1 2021, filed 15 Apr 2021.